Prelude Therapeutics Inc., a clinical-stage precision oncology company, will participate in the Citizens Life Sciences Conference in New York on May 7, 2025. The company's CEO Kris Vaddi, President and Chief Medical Officer Jane Huang, and Chief Scientific Officer Peggy Scherle will engage in a fireside chat at the event.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.